Transgenic rats as models for studying the role of ornithine decarboxylase expression in permanent middle cerebral artery occlusion

Stroke

Volumn 28, Issue 3, 1997, Pages 639-645

  Lukkarinen, Jouko ^b   Gröhn, Olli H J ^b   Sinervirta, Riitta ^b   Järvinen, Aki ^b   Kauppinen, Risto A ^a   Jänne, Juhani ^b   Alhonen, Leena I ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NONE

Author keywords

cerebral ischemia, focal; nuclear magnetic resonance; polyamines; rats transgenic

Indexed keywords

ORNITHINE DECARBOXYLASE; POLYAMINE; PUTRESCINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE ACTIVATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYAMINE METABOLISM; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0342813146     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.3.639     Document Type: Article

References (45)

1. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A. 1991;88:11158-11162.
2. Aguzzi A, Brandner S, Sure U, Rüedi D, Isenmann S. Transgenic and knock-out mice: models of neurological disease. Brain Pathol. 1994;4:3-20.
3. Kauppinen RA, Alhonen LI. Transgenic animals as models in the study of neurobiological role of polyamines. Prog Neurobiol. 1995; 47:545-563.
4. Halmekytö M, Syrjänen K, Jänne J, Alhonen L. Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene. Biochem Biophys Res Commun. 1992;187:493-497.
5. Megosh L, Gilmour SK, Rosson D, Soler AP, Blessing M, Sawicki JA, O'Brien TG. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res. 1995;55:4205-4209.
6. Wedgwood MA, Wolstencroft JH. Effects of spermine and spermidine on single brainstem neurones. Neuropharmacology. 1977;16: 445-446.
7. 3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem. 1988;51: 830-836.
8. Lerma J. Spermine regulates N-methyl-D-aspartate receptor desensitization. Neuron. 1992;8:343-352.
9. Paschen W. Polyamine metabolism in reversible cerebral ischemia. Cerebrovasc Brain Metab Rev. 1992;4:59-88.
10. Lipton SA. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox state of nitric oxide. Trends Neurosci. 1993;16:527-532.
11. 2+ fluxes and transmitter release in potassium-depolarized synaptosomes. Biochem Biophys Res Commun. 1985; 133:563-573.
12. Bondy SC, Walker CH. Polyamines contribute to calcium-stimulated release of aspartate from brain particulate fractions. Brain Res. 1986;371:96-100.
13. 2+ concentration in the brain of transgenic mice overexpressing human ornithine decarboxylase gene. J Neurochem. 1992;58:831-836.
14. Halonen T, Sivenius J, Miettinen R, Halmekytö M, Kauppinen R, Sinervirta R, Alakuijala L, Alhonen L, MacDonald E, Jänne J, Riekkinen PJS. Elevated seizure threshold and impaired spatial learning in transgenic mice with putrescine overproduction in the brain., Eur J Neurosci. 1993;5:1233-1239.
15. Paschen W, Schmidt-Kastner R, Djuricic B, Meese C, Linn F, Hossmann K-A. Polyamine changes in reversible cerebral ischemia. J Neurochem. 1987;49:35-37.
16. Müller M, Cleef M, Röhn G, Bonnekoh P, Pajunen AEI, Bernstein H-G, Paschen W. Ornithine decarboxylase in reversible cerebral ischemia: an immunohistochemical study. Acta Neuropathol (Berl). 1991;83:39-45.
17. Lukkarinen J, Kauppinen RA, Koistinaho J, Halmekytö M, Alhonen L, Jänne J. Cerebral energy metabolism and immediate early gene induction following severe incomplete ischaemia in transgenic mice overexpressing the human ornithine decarboxylase gene: evidence that putrescine is not neurotoxic in vivo. Eur J Neurosci. 1995;7:1940-1949.
18. Sauer D, Martin P, Allegrini PR, Bernasconi P, Amacker H, Fagg GE. Differing effects of α-difluoromethylornithine and CGP 40116 on polyamine levels and infarct volume in rat model of focal cerebral ischemia. Neurosci Lett. 1992;141:131-135.
19. Komulainen H, Bondy SC. Transient elevation of intrasynaptosomal free calcium by putrescine. Brain Res. 1987;401:50-54.
20. Gilad GM, Gilad VH. Polyamines can protect against ischemia-induced nerve cell death in gerbil forebrain. Exp Neurol. 1991:111: 349-355.
21. Alhonen L, Halmekytö M, Kosma V-M, Wahlfors J, Kauppinen R, Jänne J. Life-long over-expression of ornithine decarboxylase (ODC) gene in transgenic mice does not lead to generally enhanced tumorigenesis or neuronal degeneration. Int J Cancer. 1995;63: 402-404.
22. Hogan B, Constantine F, Lacy E. Manipulating the Mouse Embryo. New York, NY: Cold Spring Harbor Laboratory; 1986.
23. Halmekytö M, Hyttinen J-M, Sinervirta R, Utriainen M, Myöhänen S, Voipio H-M, Wahlfors J, Syrjànen S, Syrjänen K, Alhonen L, Jänne J. Transgenic mice aberrantly expressing human ornithine decarboxylase gene. J Biol Chem. 1991;266:19746-19751.
24. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 1986;17:738-743.
25. Jänne J, Williams-Ashman HG. On the purification of L-ornithine decarboxylase from rat prostate and effects of thiol compounds on the enzyme. J Biol Chem. 1971;246:1725-1732.
26. Hyvönen T, Keinänen TA, Khomutov AR, Khomutov RM, Eloranta TO. Monitoring of the uptake and metabolism of aminooxy analogues of polyamines in cultured cells by high-performance liquid chromatography. J Chromatogr. 1992;574:17-21.
27. Stejskal EO, Tanner JE. Spin diffusion measurements: spin-echoes in the presence of a time-dependent field gradient. J Chem Phys. 1965;42:288-292.
28. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
29. Muszynski CA, Robertson CS, Goodman JC, Henley CM. DFMO reduces cortical infarct volume after cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1993;13:1033-1037.
30. Rao AM, Baskaya MK, Maley ME, Prasad MR, Dempsey RJ. Ornithine decarboxylase activity and edema formation in cerebral ischemia of conscious gerbils. J Neurochem. 1995;65:2639-2643.
31. Chan PH, Kamii H, Yang G, Gafni J, Epstein CJ, Carlson E, Reola L. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport. 1993;5:293-296.
32. Halmekytö M, Alhonen L, Alakuijala L, Jänne J. Transgenic mice over-producing putrescine in their tissues do not convert the diamine into higher polyamines. Biochem J. 1993;291:505-508.
33. Subramaniam S, McGonigle P. Regional heterogeneity of polyamine effects on the N-methyl-D-aspartate receptor in rat brain. J Neurochem. 1993;60:2276-2284.
34. 3H]MK-801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol. 1989:36:575-581.
35. McGurk JF, Bennett MVL, Zukin RS. Polyamines potentiate responses of N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Proc Natl Acad Sci USA. 1990;87:9971-9974.
36. Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, Gaudilliere B, MacKenzie ET, Rousseau J, Scatton B, Wick A. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents, I: evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther. 1988;247:1211-1221.
37. 31P saturation transfer. J Pharmacol Exp Ther. 1989;251:700-706.
38. Knight RA, Dereski MO, Helpern JA, Ordidge RJ, Chopp M. Magnetic resonance imaging assessment of evolving focal cerebral ischemia: comparison with histopathology in rats. Stroke. 1994;25: 1252-1261.
39. van Bruggen N, Roberts TPL, Cremer JE. The application of magnetic resonance imaging to the study of experimental cerebral ischaemia. Cerebrovasc Brain Metab Rev. 1994;6:180-210.
40. Moseley ME, Cohen Y, Mintorovitch J, Chileuitt L, Shimizu H, Kucharczyk J, Wendland MF, Weinstein PR. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med. 1990;14: 330-346.
41. Busza AL, Allen KL, King MD, van Bruggen N, Williams SR, Gadian DG. Diffusion weighted imaging studies of cerebral ischemia in gerbils: potential relevance to energy failure. Stroke. 1992;23:1601-1612.
42. Mori S, van Zijl PCM. Diffusion weighting by the trace of the diffusion tensor within a single scan. Magn Reson Med. 1995;33:41-52.
43. Benveniste H, Hedlund LW, Johnson GA. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke. 1993;23:746-754.
44. Yongbi MN, Ding S, Dunn JF. A modified sub-second fast-STEAM sequence incorporating bipolar gradients for in vivo diffusion imaging. Magn Reson Med. 1996;35:911-916.
45. Kucharczyk J, Mintorovitch J, Moseley ME, Asgari HS, Sevick RJ. Derugin N, Norman D. Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476. Radiology. 1991;179:221-227.